VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,919,676 | +442658.1% | 631,769 | +999.7% | 0.00% | +200.0% |
| Q1 2023 | $1,337 | +15.7% | 57,451 | +25.7% | 0.00% | 0.0% |
| Q4 2022 | $1,156 | -100.0% | 45,691 | -84.2% | 0.00% | -66.7% |
| Q3 2022 | $5,575,000 | -68.1% | 289,170 | -57.9% | 0.00% | -72.7% |
| Q2 2022 | $17,503,000 | -85.7% | 687,199 | -85.5% | 0.01% | -83.1% |
| Q1 2022 | $122,124,000 | +201.4% | 4,748,194 | +390.6% | 0.06% | +209.5% |
| Q4 2021 | $40,523,000 | +463.8% | 967,825 | +485.9% | 0.02% | +425.0% |
| Q3 2021 | $7,188,000 | -52.1% | 165,173 | -47.9% | 0.00% | -55.6% |
| Q2 2021 | $14,995,000 | +624.4% | 317,150 | +685.4% | 0.01% | +800.0% |
| Q1 2021 | $2,070,000 | -62.4% | 40,379 | -80.4% | 0.00% | -75.0% |
| Q4 2020 | $5,508,000 | +226.1% | 205,679 | +399.0% | 0.00% | +33.3% |
| Q2 2020 | $1,689,000 | – | 41,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |